16:18 EDT Serina Therapeutics (SER) files $100M mixed securities shelf
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SER:
- Serina Therapeutics Unveils Breakthrough in POZ-Lipid Technology
- Serina Therapeutics to present on POZ-lipid technology at ACS Spring 2025
- Serina Therapeutics initiated with a Buy at JonesResearch
- Serina Therapeutics Appoints Dr. Venkatesan to Board
- Serina Therapeutics receives funding to advance SER-252 into clinical trial